Analysts Set Plexus Corp. (NASDAQ:PLXS) Price Target at $273.00

Shares of Plexus Corp. (NASDAQ:PLXSGet Free Report) have received an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $273.00.

A number of analysts have recently commented on the company. Raymond James Financial restated an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research report on Thursday, April 30th. Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a research note on Friday, July 31st. Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Finally, Zacks Research upgraded shares of Plexus from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th.

Read Our Latest Stock Report on PLXS

Insider Transactions at Plexus

In related news, insider Michael J. Running sold 510 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $272.17, for a total transaction of $138,806.70. Following the completion of the transaction, the insider owned 665 shares in the company, valued at $180,993.05. This represents a 43.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $294.98, for a total transaction of $442,470.00. Following the completion of the transaction, the chief executive officer directly owned 68,888 shares in the company, valued at $20,320,582.24. This represents a 2.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 5,510 shares of company stock valued at $1,525,182 in the last three months. Corporate insiders own 1.78% of the company’s stock.

Institutional Trading of Plexus

Institutional investors have recently made changes to their positions in the company. Inspire Investing LLC boosted its stake in Plexus by 1.6% during the 4th quarter. Inspire Investing LLC now owns 3,178 shares of the technology company’s stock worth $467,000 after purchasing an additional 50 shares during the period. Allworth Financial LP grew its position in Plexus by 20.8% during the 4th quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock worth $44,000 after purchasing an additional 52 shares during the last quarter. Maryland State Retirement & Pension System increased its stake in Plexus by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 3,940 shares of the technology company’s stock valued at $579,000 after purchasing an additional 60 shares during the period. Trust Point Inc. increased its stake in Plexus by 5.5% in the second quarter. Trust Point Inc. now owns 1,308 shares of the technology company’s stock valued at $393,000 after purchasing an additional 68 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its holdings in shares of Plexus by 1.2% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock valued at $908,000 after buying an additional 71 shares during the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

Plexus Trading Down 1.0%

PLXS stock opened at $267.68 on Tuesday. Plexus has a 52-week low of $126.86 and a 52-week high of $307.06. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. The firm has a market cap of $7.16 billion, a P/E ratio of 39.48 and a beta of 0.90. The company’s 50-day simple moving average is $273.44 and its 200-day simple moving average is $238.22.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.19. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%.Plexus’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, equities analysts forecast that Plexus will post 6.73 EPS for the current fiscal year.

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

See Also

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.